These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 4074424

  • 1. The metabolism of a new antithrombotic and vasodilating agent, cilostazol, in rat, dog and man.
    Akiyama H, Kudo S, Shimizu T.
    Arzneimittelforschung; 1985; 35(7A):1133-40. PubMed ID: 4074424
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Physico-chemical properties and stability of cilostazol.
    Shimizu T, Osumi T, Niimi K, Nakagawa K.
    Arzneimittelforschung; 1985; 35(7A):1117-23. PubMed ID: 4074422
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of cilostazol, a new antithrombotic drug, on cerebral circulation.
    Kawamura K, Watanabe K, Kimura Y.
    Arzneimittelforschung; 1985; 35(7A):1149-54. PubMed ID: 4074427
    [Abstract] [Full Text] [Related]

  • 9. Effect of cilostazol, a new antithrombotic drug, on an experimental model of peripheral circulation insufficiency.
    Kawamura K, Fujita S, Tani T, Kimura Y.
    Arzneimittelforschung; 1985; 35(7A):1154-6. PubMed ID: 4074428
    [Abstract] [Full Text] [Related]

  • 10. Phase I study of cilostazol. Safety evaluation at increasing single doses in healthy volunteers.
    Niki T, Mori H.
    Arzneimittelforschung; 1985; 35(7A):1173-85. PubMed ID: 4074430
    [Abstract] [Full Text] [Related]

  • 11. Effect of cilostazol on platelet aggregation and experimental thrombosis.
    Kimura Y, Tani T, Kanbe T, Watanabe K.
    Arzneimittelforschung; 1985; 35(7A):1144-9. PubMed ID: 4074426
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic effects of the antithrombotic drug cilostazol in chronic arterial occlusion in the extremities.
    Kamiya T, Sakaguchi S.
    Arzneimittelforschung; 1985; 35(7A):1201-3. PubMed ID: 4074435
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hemodynamic effect of cilostazol on increasing peripheral blood flow in arteriosclerosis obliterans.
    Yasuda K, Sakuma M, Tanabe T.
    Arzneimittelforschung; 1985; 35(7A):1198-200. PubMed ID: 4074434
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.